Add to that an environment filled with ultraprocessed foods, oversized portions, high stress and limited time for movement, and its no surprise that so many peoples weight ends up yo-yoing despite their best efforts
(12, 13) By improving glycemic control, enhancing insulin sensitivity, and reducing adiposity, GLP-1 therapies may decrease bone marrow adipose tissue (BMAT) formation and mitigate the harmful effects of hyperglycemia on bone quality
Kosinski, M
Currently, there is much interest in delivering GLP-1 receptor agonists via alternate, non-invasive routes with high bioavailability and least side effects as possible
Snack only when needed to meet protein goals (100-120g daily) or bridge 5+ hour gaps between meals
Bone Health Concerns (Osteoporosis) One of the most serious but under-discussed long-term risks of GLP-1 medications is their potential impact on bone health